Spencer S. Lee
CIK: 0001207134
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CHEMED CORP
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Nov 2, 2026CHE
CHEMED CORP
Sale(S)Direct920 shares at avg. $537.17$494K - Oct 20, 2026CHE
CHEMED CORP
Award(A)DirectStock Option (right to buy with tandem tax withholding)
7.1K shares at avg. $512.64- - Sep 30, 2026CHE
CHEMED CORP
Exercise(M)Direct12.1K shares at avg. $445.35$5.4M - Sep 30, 2026CHE
CHEMED CORP
Tax Payment(F)Direct11.2K shares at avg. $508.93$5.7M - Aug 21, 2026CHE
CHEMED CORP
Sale(S)Direct1K shares at avg. $541.04$541K - Feb 13, 2026CHE
CHEMED CORP
Exercise(M)Direct499 shares at avg. $469.56$234K - Feb 13, 2026CHE
CHEMED CORP
Award(A)DirectPerformance Stock Units
960 shares- - Feb 13, 2026CHE
CHEMED CORP
Tax Payment(F)Direct154 shares at avg. $469.56$72K - Feb 13, 2026CHE
CHEMED CORP
Exercise(M)Direct0 shares at avg. $469.56- - Nov 19, 2025CHE
CHEMED CORP
Gift(G)Direct60 shares- - Oct 21, 2025CHE
CHEMED CORP
Award(A)DirectStock Option (right to buy with tandem tax withholding)
12.8K shares at avg. $443.79- - May 16, 2025CHE
CHEMED CORP
Sale(S)Direct1.5K shares at avg. $577.99$867K - May 7, 2025CHE
CHEMED CORP
Sale(S)Direct1.5K shares at avg. $577.86$867K - Mar 3, 2025CHE
CHEMED CORP
Sale(S)Direct1.3K shares at avg. $592.25$785K - Feb 14, 2025CHE
CHEMED CORP
Tax Payment(F)Direct342 shares at avg. $553.39$189K - Feb 14, 2025CHE
CHEMED CORP
Exercise(M)Direct249 shares at avg. $553.39$138K - Feb 14, 2025CHE
CHEMED CORP
Exercise(M)Direct824 shares at avg. $553.39$456K - Feb 14, 2025CHE
CHEMED CORP
Award(A)DirectPerformance Stock Units
822 shares- - Dec 2, 2024CHE
CHEMED CORP
Gift(G)Direct65 shares- - Nov 27, 2024CHE
CHEMED CORP
Sale(S)Direct732 shares at avg. $575.62$421K - Nov 22, 2024CHE
CHEMED CORP
Sale(S)Direct1K shares at avg. $565.71$566K - Oct 22, 2024CHE
CHEMED CORP
Award(A)DirectStock Option (right to buy with tandem tax withholding)
9.1K shares at avg. $597.70-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Nov 2, 2026 | CHE CHEMED CORP | Sale(S) | 920 | $537.17 | $494,196 | Direct |
| Oct 20, 2026 | CHE CHEMED CORP | Award(A) Stock Option (right to buy with tandem tax withholding) | 7,125 | $512.64 | - | Direct |
| Sep 30, 2026 | CHE CHEMED CORP | Exercise(M) | 12,099 | $445.35 | $5,388,290 | Direct |
| Sep 30, 2026 | CHE CHEMED CORP | Tax Payment(F) | 11,160 | $508.93 | $5,679,659 | Direct |
| Aug 21, 2026 | CHE CHEMED CORP | Sale(S) | 1,000 | $541.04 | $541,040 | Direct |
| Feb 13, 2026 | CHE CHEMED CORP | Exercise(M) | 499 | $469.56 | $234,310 | Direct |
| Feb 13, 2026 | CHE CHEMED CORP | Award(A) Performance Stock Units | 960 | - | - | Direct |
| Feb 13, 2026 | CHE CHEMED CORP | Tax Payment(F) | 154 | $469.56 | $72,312 | Direct |
| Feb 13, 2026 | CHE CHEMED CORP | Exercise(M) | 0 | $469.56 | $0 | Direct |
| Nov 19, 2025 | CHE CHEMED CORP | Gift(G) | 60 | - | - | Direct |
| Oct 21, 2025 | CHE CHEMED CORP | Award(A) Stock Option (right to buy with tandem tax withholding) | 12,759 | $443.79 | - | Direct |
| May 16, 2025 | CHE CHEMED CORP | Sale(S) | 1,500 | $577.99 | $866,985 | Direct |
| May 7, 2025 | CHE CHEMED CORP | Sale(S) | 1,500 | $577.86 | $866,790 | Direct |
| Mar 3, 2025 | CHE CHEMED CORP | Sale(S) | 1,326 | $592.25 | $785,324 | Direct |
| Feb 14, 2025 | CHE CHEMED CORP | Tax Payment(F) | 342 | $553.39 | $189,259 | Direct |
| Feb 14, 2025 | CHE CHEMED CORP | Exercise(M) | 249 | $553.39 | $137,794 | Direct |
| Feb 14, 2025 | CHE CHEMED CORP | Exercise(M) | 824 | $553.39 | $455,993 | Direct |
| Feb 14, 2025 | CHE CHEMED CORP | Award(A) Performance Stock Units | 822 | - | - | Direct |
| Dec 2, 2024 | CHE CHEMED CORP | Gift(G) | 65 | - | $0 | Direct |
| Nov 27, 2024 | CHE CHEMED CORP | Sale(S) | 732 | $575.62 | $421,356 | Direct |
| Nov 22, 2024 | CHE CHEMED CORP | Sale(S) | 1,000 | $565.71 | $565,710 | Direct |
| Oct 22, 2024 | CHE CHEMED CORP | Award(A) Stock Option (right to buy with tandem tax withholding) | 9,105 | $597.70 | - | Direct |
1-22 of 22 transactions
About LEE SPENCER S
LEE SPENCER S (SEC CIK 0001207134) files insider reports with the SEC as executive vice president of CHEMED CORP (CHE).
Signal8 holds 15 ownership filings by LEE SPENCER S, all Form 4s, filed between Oct 23, 2024 and Nov 3, 2026. Those filings report 22 transactions, from Oct 22, 2024 to Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on LEE SPENCER S's filings is in CINCINNATI, OH.
Recent filings by LEE SPENCER S
- Nov 2, 2026: Open-market sale of CHE shares (Form 4, code S).
- Oct 20, 2026: Grant or award of CHE derivative securities (Form 4, code A).
- Sep 30, 2026: Option exercise of CHE shares (Form 4, code M).
- Sep 30, 2026: Tax withholding of CHE shares (Form 4, code F).
- Aug 21, 2026: Open-market sale of CHE shares (Form 4, code S).
Other insiders filing for CHEMED CORP (CHE)
- Wherley Joel L, CEO - Vitas Healthcare
- Judkins Brian C, VP and Chief Legal Officer
- HUTTON THOMAS C, vice president
- Witzeman Michael D, VP & Chief Financial Officer
- MCNAMARA KEVIN J, president and CEO
- GRACE PATRICK P, Director